Dexcom Maintains Full-Year Revenue Forecast After Exceeding Quarterly Estimates

Medical device company Dexcom reaffirmed its full-year revenue forecast after surpassing Wall Street's quarterly estimates, driven by strong demand for continuous glucose monitors. Despite the positive results, shares fell in after-hours trading.

By Reuters Thu, April 30, 2026 at 11:56 PM GMT+3 1 min read · Yahoo Finance · April 30, 2026, 20:56 UTC

Dexcom Maintains Full-Year Revenue Forecast After Exceeding Quarterly Estimates

Tickers: $ABT $DXCM $MDT

Topics: CGM diabetes_care medical_devices revenue_forecast

Read the full article at Yahoo Finance

More World news

SchoolWise Partners Advises on Sale of Wyalusing Valley and Wysox Children's Centers PR Newswire · November 12, 2026, 15:57 UTC
Jensen Huang Resigns as Nvidia CEO Amid Personal Scandal and Leadership Crisis CNBC · November 12, 2026, 15:45 UTC
Keurig Dr Pepper Launches $2 Billion Equity Offering to Reduce Debt Ahead of Corporate Split Seeking Alpha · November 12, 2026, 15:51 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC
Oman Investment Authority Signs Multi-Billion Dollar Investment Package with Chinese Partners PR Newswire · November 12, 2026, 15:52 UTC
Nvidia Shares Drop 35% Following Resignation of CEO Jensen Huang Motley Fool · November 12, 2026, 15:49 UTC
Pomerantz Law Firm Investigates Potential Securities Fraud at ClearPoint Neuro (CLPT) PR Newswire · November 12, 2026, 15:50 UTC
Nvidia CEO Jensen Huang Resigns Amid Board Investigation The Verge · November 12, 2026, 15:48 UTC
GFL Environmental Shares Decline Following Preferred Share Conversion and Block Trade Seeking Alpha · November 12, 2026, 15:48 UTC